Wellnex Life has launched its Wellness Life medicinal cannabis brand with joint venture partner OneLife Botanicals and appointed Dr Mihindu Jayasuriya and Dr Tony Farag as senior medical advisors.
The range is available for prescription via the special access scheme and will be distributed by the Entourage Effect.
The medicinal cannabis division of Wellnex will be led by Dr Sylvia Victor, the former chief commercial officer and head of research and development at Releaf Group.
Dr Jayasuriya (also ex-Releaf Group) and Dr Farag will provide training and education to select pharmacies and prescribe Wellness Life products to patients.
Wellnex Life CEO George Karafotias said: “The launch of Wellness Life is an exciting development, and we are well positioned to take advantage of the growing demand for prescription medicinal cannabis.
“We have quality Australian product manufactured by OneLife Botanicals, an experienced team led by Dr Sylvia Victor and great partners which makes this project very exciting.”
